Mgl Pharma & Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth -0.26%
- Ebitda -78.59%
- Net Worth -9.30%
- Total Assets 44.03%
About Mgl Pharma & Chemicals
Mgl Pharma & Chemicals Private Limited (MPCPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 March 2010 and has a history of 14 years and ten months. Its registered office is in Jaunpur, Uttar Pradesh, India.
The Corporate was formerly known as Hale Health Foods Private Limited. The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deep Sonkar, Harsh Sonkar, and Lata Sonkar serve as directors at the Company.
Company Details
-
Location
Jaunpur, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24233UP2010PTC039998
-
Company No.
039998
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Mar 2010
-
Date of AGM
29 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Mgl Pharma & Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deep Sonkar
|
Managing Director | 27-Jan-2020 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Harsh Sonkar
|
Director | 25-Oct-2024 | Current |
|
Lata Sonkar
|
Director | 10-Dec-2014 | Current |
Financial Performance of Mgl Pharma & Chemicals.
Mgl Pharma & Chemicals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 0.26% decrease in profit. The company's net worth dipped by a decrease of 9.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mgl Pharma & Chemicals?
In 2017, Mgl Pharma & Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mgl Pharma & Chemicals?
Unlock and access historical data on people associated with Mgl Pharma & Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mgl Pharma & Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mgl Pharma & Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
